1-s2.0-s1751722213002801-main

4
Urinary tract infections in children Lyda Jadresi c  Abstract Urinary tract infection (UTI) is a common bacterial infection that can affect infants and children. The severity of illness depends on microbial viru- lence and host susceptibility. It has a number of different ways to manifest itself clinically ranging from a mild cystitis to a presentation with systemic symptoms such as a nonspecic fever, vomiting, failure to thrive or irritability or with signicant dehydration and electrolyte imbalance which can be seen in infants in the rst 3 months of life. It is therefore a ubiquitous differential diagnosis in many children presenting both in primary care and in the hospital setting. In mos t chi ldr en ur ina ry inf ect ion s areisola tedacuteinfec tio ns fro m whi ch they recover quickly. In a small minority of children urinary infections can be associated with underlying signicant pathology: either they are associated with congenital renal tract malformations such as renal dysplasia and/or hydronephrosis or if they have recurrent infections this may lead to renal scarrin g, parti cular ly if the infect ions are associ atedwith system ic sympto ms. Keywords  acute pyelonephritis; bladder function; constipation; cystitis; fever; non  Escherichia coli  urine infection; renal scarring; urine infection; uropathogenic  Escherichia coli Denition The denition of a urinary tract infection consists of  bacteriuria in the presence of symptoms. Bacterial growth of more than 10 5 is regarded as the threshold number for a signicant bacterial growth; however, the evidence base for this threshold is weak. There is evidence that infants may have urine infections with lower bacterial counts. Although in most instances there is also pyuria this may sometimes be absent. Asymptomatic bacteriuria needs no treatment or investigation. Causative organisms and host response The bacteria that cause urinary tract infections originate from gut andperi nea l ora.Theurinarytractiskeptsterileby a normalurine ow and the innate (or nonspecic) local immune system. The ability of bacteria to cause urinary infections depends on bacterial virulence factors as well as host factors. Uropathogenic  E. coli (UPE C) have spec ic viru lenc e fact ors whic h enab le themto atta ck the uroepithelium, one of these is the possession of P mbriae which increase bacterial adhesion to the mucosa and facilitate its exposure to bacterial toxins. UPEC are cause 70e90% of commu- nity acqu ired urin ary trac t infe ctions. Foll owin g mucos al adhes ion the innate immune response is stimulated and various families of Toll like receptors (TLRs) play a key role in the activation of transcription factors, and production of a variety of cytokines, in- terferons and their regulatory factors. The degree of renal damage has been found to be corre lated to high blood and urinary levels of various cytokine s, for example Interleukin 6 (IL-6), which induces fever, stimulates hepatocyte production of C reactive protein and acts on theuroth eli um to pro duce IgA ant ibo di es. Ove r thelast few years it hasbecome incr easin gly clea r thatthere isgenetic vari atio n in innate immunity, e.g. affecting the expression and function of TLRs, Inter feron Regulator Factor 3 (IRF3) and IL-8 receptors, resulting in clinical differences in the host response ranging from being able to tolerate bacteria asymptomatically (asymptomatic bact eriur ia) to mount ing a severe ina mmatoryresponseresulting in acute pyelonephritis. The familial occurrence of recurrent UTI has been known about for someti me and may beexpl ai ne d by this typ e of gene tica llytransmitteddefectsin sin gle prot einsinvolve d in the innate immunity of the uroepithelium to uropathogens. Most children with UTI do not have underlying structural abnormalities and this area of study, which is already seeing major expansion, sho uldprovidein thefuturethetools forident ify ing children at risk of renal damage as well as enabling the development of specic biological agents to prevent recurrent UTI. Other bacteria are other coliforms such as Klebsiella as well as organ isms such as  Proteus mirabilis, Pseu domon as, coagu lase negative Staphs, Streptococci (e.g. Group B strep, Enterococci), Staphylococcus aureus  and occasionally  Haemophilus inuenzae as we ll as oth ers. The se non  E. col i  orga nisms often do not possess the aforementioned virulence factors seen in UPEC and it has been shown that their ability to cause urina ry infe ction s depe nds heavily on the pres ence of host factors , parti cula rly structural urinary tract abnormalities leading to urinary stasis. There fore, one of the indicati ons for inves tigat ing the urinary tract in children is the type of organism involved in the infection. Incidence and epidemiology Reliable measurements of the incidence of UTI in children have been difcult. Epid emiol ogica lly strong stud ies from Swed en Key points C Urine for microscopy and culture should not be collected by bag or pad; a clean catch sample should be obtained with the option in hospital of a catheter or suprapubic sample. C Infections with non  Escherichia coli  UTIs are associated with increa sed risk of under lying obstru ctive structu ral abnormalities. C Clinical features inform the decision as to which children need renal imaging. C Childre n wit h rec urren t UTIs sho uld have a basic clinical assessment of bladder function. C Gene tic diff erences in inna te immu nity and uropathogen s virulence factors play a key role in the risk of acute pyelonephritis. Lyda Jadresi c  FRCPCH MD is Consultant Paediatrician at the Gloucestershire Hospital NHS T rust, Gloucester , UK. Conicts of interest: The author was a membe r of theNICEGuide lineDeve lopmen t Gro upfor Chil dho odUTI which  publish ed the current guid eline back in 2007 . The author partici pated in the development of NICE Quality Standards of this guideline and i nits recent Evidence Update. The author had a grant from HQIP to carry out a multisite audit of the NICE UTI guideline both in 1ry and 2ry care centres; no monies will come to the author or her department apart from covering travel expenses to meetings in London and Birmingham. SYMPOSIUM: NEPHROLOGY PAEDIATRICS AND CHILD HEALTH 24:7  289   2013 Elsevier Ltd. All rights reserved.

Upload: juan-favela-hernandez

Post on 12-Oct-2015

3 views

Category:

Documents


0 download

TRANSCRIPT

  • Urinary tract infections inchildrenLyda Jadresic

    Abstract

    biological agents to prevent recurrent UTI.

    Other bacteria are other coliforms such as Klebsiella as well as

    organisms such as Proteus mirabilis, Pseudomonas, coagulase

    negative Staphs, Streptococci (e.g. Group B strep, Enterococci),

    Staphylococcus aureus and occasionally Haemophilus influenzae

    as well as others. These non E. coli organisms often do not

    possess the aforementioned virulence factors seen in UPEC and it

    has been shown that their ability to cause urinary infections

    depends heavily on the presence of host factors, particularly

    structural urinary tract abnormalities leading to urinary stasis.

    Therefore, one of the indications for investigating the urinary

    tract in children is the type of organism involved in the infection.

    Incidence and epidemiology

    Reliable measurements of the incidence of UTI in children have

    been difficult. Epidemiologically strong studies from Sweden

    member of theNICEGuidelineDevelopment Group for ChildhoodUTIwhich

    SYMPOSIUM: NEPHROLOGYpublished the current guideline back in 2007. The author participated in

    the development of NICE Quality Standards of this guideline and i nits

    recent Evidence Update. The author had a grant from HQIP to carry out a

    multisite audit of the NICE UTI guideline both in 1ry and 2ry care centres;

    no monies will come to the author or her department apart from covering

    travel expenses to meetings in London and Birmingham.Urinary tract infection (UTI) is a common bacterial infection that can affect

    infants and children. The severity of illness depends on microbial viru-

    lence and host susceptibility.

    It has a number of different ways to manifest itself clinically ranging

    from a mild cystitis to a presentation with systemic symptoms such as a

    nonspecific fever, vomiting, failure to thrive or irritability or with significant

    dehydration and electrolyte imbalance which can be seen in infants in the

    first 3 months of life. It is therefore a ubiquitous differential diagnosis in

    many children presenting both in primary care and in the hospital setting.

    Inmost children urinary infections are isolated acute infections fromwhich

    they recover quickly. In a small minority of children urinary infections can be

    associated with underlying significant pathology: either they are associated

    with congenital renal tract malformations such as renal dysplasia and/or

    hydronephrosis or if they have recurrent infections this may lead to renal

    scarring, particularly if the infections are associatedwith systemic symptoms.

    Keywords acute pyelonephritis; bladder function; constipation; cystitis;

    fever; non Escherichia coli urine infection; renal scarring; urine infection;

    uropathogenic Escherichia coli

    Definition

    The definition of a urinary tract infection consists of bacteriuria

    in the presence of symptoms. Bacterial growth of more than 105

    is regarded as the threshold number for a significant bacterial

    growth; however, the evidence base for this threshold is weak.

    There is evidence that infants may have urine infections with

    lower bacterial counts. Although in most instances there is also

    pyuria this may sometimes be absent. Asymptomatic bacteriuria

    needs no treatment or investigation.

    Causative organisms and host response

    The bacteria that cause urinary tract infections originate from gut

    andperineal flora. Theurinary tract is kept sterile by a normal urine

    flow and the innate (or nonspecific) local immune system. The

    ability of bacteria to cause urinary infections depends on bacterial

    virulence factors as well as host factors. Uropathogenic E. coli

    (UPEC) have specific virulence factorswhich enable them to attack

    Lyda Jadresic FRCPCH MD is Consultant Paediatrician at the Gloucestershire

    Hospital NHS Trust, Gloucester, UK. Conflicts of interest: The author was aPAEDIATRICS AND CHILD HEALTH 24:7 289the uroepithelium, one of these is the possession of P fimbriae

    which increase bacterial adhesion to the mucosa and facilitate its

    exposure to bacterial toxins. UPEC are cause 70e90% of commu-

    nity acquired urinary tract infections. Followingmucosal adhesion

    the innate immune response is stimulated and various families of

    Toll like receptors (TLRs) play a key role in the activation of

    transcription factors, and production of a variety of cytokines, in-

    terferons and their regulatory factors. The degree of renal damage

    has been found to be correlated to high blood and urinary levels of

    various cytokines, for example Interleukin 6 (IL-6), which induces

    fever, stimulates hepatocyte production of C reactive protein and

    acts on the urothelium to produce IgA antibodies. Over the last few

    years it has become increasingly clear that there is genetic variation

    in innate immunity, e.g. affecting the expression and function of

    TLRs, Interferon Regulator Factor 3 (IRF3) and IL-8 receptors,

    resulting in clinical differences in the host response ranging from

    being able to tolerate bacteria asymptomatically (asymptomatic

    bacteriuria) to mounting a severe inflammatory response resulting

    in acute pyelonephritis. The familial occurrence of recurrent UTI

    has been known about for some time andmay be explained by this

    type of genetically transmitteddefects in single proteins involved in

    the innate immunity of the uroepithelium to uropathogens. Most

    children with UTI do not have underlying structural abnormalities

    and this area of study, which is already seeing major expansion,

    should provide in the future the tools for identifying children at risk

    of renal damage as well as enabling the development of specific

    Key points

    C Urine for microscopy and culture should not be collected by

    bag or pad; a clean catch sample should be obtained with the

    option in hospital of a catheter or suprapubic sample.

    C Infections with non Escherichia coli UTIs are associated with

    increased risk of underlying obstructive structural abnormalities.

    C Clinical features inform the decision as to which children need

    renal imaging.

    C Children with recurrent UTIs should have a basic clinical

    assessment of bladder function.

    C Genetic differences in innate immunity and uropathogens

    virulence factors play a key role in the risk of acute

    pyelonephritis. 2013 Elsevier Ltd. All rights reserved.

  • SYMPOSIUM: NEPHROLOGYhave reported that around 2% of boys and girls aged less than 2

    years have a UTI. Based on evidence extracted from Swedish and

    UK data, approximately 10% of girls and 3% of boys will have

    had a UTI before the age 16 years. In infancy, the incidence of

    UTI in the under 3 months of age is higher in boys most probably

    reflecting a higher incidence of obstructive congenital urogenital

    abnormalities in males. After this age, girls have a higher inci-

    dence of UTI. Girls are more likely to have recurrences of UTI.

    Clinical presentation and differential diagnosis

    The clinical presentation can be divided into two types. In a

    lower tract UTI or cystitis the symptoms are confined to the

    bladder and consist of dysuria, frequency, incontinence, urgency

    of micturition and abdominal pain. An upper tract UTI or acute

    pyelonephritis is defined by the presence of fever (38 C) orother systemic symptoms such as loin pain or vomiting and in

    infants typically failure to thrive or persistent irritability. Babies

    under 3 months of age can occasionally present with dehydra-

    tion, hyponatraemia and hyperkalaemia mimicking the findings

    in congenital adrenal hyperplasia. The symptoms in the very

    young children particularly infants are nonspecific and it is safer

    to assume that they are upper tract in nature.

    The diagnosis needs to be confirmed by obtaining a urine

    specimen which is sent for culture but this is difficult in children

    still in nappies. Febrile children should be assessed using the

    traffic light system of the NICE fever guideline and it is rec-

    ommended that in those with nonspecific fever regardless of the

    severity of illness should have a urinalysis.

    Large numbers of young children present with nonspecific

    symptoms to primary care and the DUTY study hopes to create

    an algorithm of presenting symptoms and signs to help select

    which children should have a urine sample taken.

    Urine analysis

    There is a significant risk of contamination of the urine sample if

    urine bags are used and this is slightly less when pads are used

    and changed every 30 minutes. The gold standard is a suprapubic

    aspiration (SPA) with ultrasound guidance although recent evi-

    dence shows that urethral in out catheterization yields reliable

    results and is better tolerated. These techniques require training

    and they are not feasible in primary care. Therefore the best and

    most practical way to try to obtain a noncontaminated sample is

    by clean catch and this should be possible in the community.

    Urine dipsticks with reagent strips to look for the presence of

    nitrite and leucocyte esterase are useful particularly to rule out

    UTI, they can be useful to rule in UTI but the likelihood ratios are

    less. They are unreliable in children under 2 years. There is not

    enough data on how reliability changes as the child gets older

    and NICE recommends that children under 3 years should have

    urgent microscopy rather than urine dipstick for the rapid diag-

    nosis of UTI.

    Antibiotics should be started after sending the sample to the

    laboratory if the dipstick is nitrite positive or bacteria are seen on

    microscopy. If the dipstick is leucocyte positive or if there is only

    pyuria on microscopy, the sample should be sent to the labora-

    tory and the decision to start empirical antibiotic treatment for

    UTI should be based on the clinical findings and the severity of

    illness. Isolated pyuria can occur in febrile children due toPAEDIATRICS AND CHILD HEALTH 24:7 290infections, viral or bacterial, other than UTI. In situations when

    the dipstick is negative for both nitrite and leucocyte esterase but

    the symptoms point to a UTI, the sample should be sent to the

    laboratory and the question of empirical treatment with antibi-

    otics prior to the culture results depends on the severity of

    illness. Febrile children should be assessed according to the NICE

    fever guideline and careful assessment of very young infants with

    possible UTI should include a decision about ruling out an

    associated meningitis in severe ill infants. This is a rare

    complication.

    Management and treatment of UTI

    Infants under 3 months with a suspected diagnosis of UTI should

    be assessed by paediatricians.

    The history and examination on all children with confirmed

    UTI should be recorded and should include the following:

    temperature hydration history suggesting previous UTI or confirmed previous UTI recurrent fever of uncertain origin antenatally-diagnosed renal abnormality family history of vesicoureteric reflux (VUR) or renal

    disease

    constipation dysfunctional voiding including urine flow enlarged bladder abdominal mass evidence of spinal lesion growth blood pressureThe vast majority of UTIs in children older than 3 months can

    be treated orally. Children with cystitis/lower tract symptoms can

    be treated with a 3 day course of antibiotic. Common and useful

    antibiotics are trimethoprim, nitrofurantoin (should not be used

    in AP/upper tract UTI), cephalexin or co-amoxiclav. The resis-

    tance of E. coli to amoxicillin is currently too high for this anti-

    biotic to be recommended as a first line antibacterial. The choice

    of antibiotic should ideally be agreed along joint guidelines with

    the local microbiology department. This is particularly important

    to contain the emergence of increasingly resistant bacteria. Chil-

    dren with AP/upper tract infection can be treated with a 7e10

    days course of oral antibiotics. Exceptions to the initiation of oral

    therapy include vomiting, evidence of circulatory shock, or the

    presence of known potential obstruction such as hydronephrosis.

    Continuing fever at the end of 48 hours in spite of suitable anti-

    biotics should be investigated with at least a repeat urine culture

    and an ultrasound of the renal tract as urinary obstruction can be

    a cause for failure to respond to antibiotics. There is no indication

    for the routine use of antibiotic prophylaxis.

    Prevention of UTI

    There have been many studies on a variety of interventions to try

    and prevent UTI in children including antibiotic prophylaxis,

    cranberry juice, probiotics, circumcision, Vitamin A, etc. The role

    of antibiotic prophylaxis has beenquestionedbyanumber ofmeta-

    analyses; it may confer a small protective effect in girls with

    recurrent infections and VUR. Proanthocyanidin-A present in

    cranberry juice, inhibits bacterial adhesion to uroepithelial cells, 2013 Elsevier Ltd. All rights reserved.

  • targeted to the minority of children whose

    puts them at risk of underlying pathology

    basic outline ofwho requires investigations is

    is followed by the full details of the imaging

    Children who need some form of renafter a first UTI include:

    C Children under 6 months of ageC Children with an atypical presentation:

    SYMPOSIUM: NEPHROLOGYhowever a recent Evidence Update by NICE found that cranberry

    juice does not appear to prevent UTIs although the evidence was

    limited. Circumcision significantly lowers the incidence of UTI but

    it does not have a role in the management of simple UTI. Under

    specialist paediatric urology guidance it may play a part in the

    management of a small subgroup of boys with recurrent UTIs or

    high grade VUR. The presence of dysfunctional bladder and or

    chronic constipation increases the risk of recurrence of UTI.

    Long term outcome

    The proportion of children found to have renal parenchymal

    defects if investigated after a first UTI is approximately 5%.

    Studies have demonstrated that bladder dysfunction can play

    a key role in UTIs and that VUR can be a secondary effect. It is

    important, therefore, to make a clinical assessment of bladder

    function in children with UTIs.

    Large, long term follow up studies from Sweden on blood

    pressure in patients known to have scarred kidneys in association

    with childhood UTI have shown no significant differences

    compared to normal controls. A nonsignificant risewas seen in the

    subgroup with bilateral scarring in association with loss of renal

    mass. The prevalence of hypertension in adults in England is high,

    affecting an average of 29%ofwomen and 32% inmen. Therefore,

    children with UTI are much more at risk of developing hyperten-

    sion as a result of life style factors rather than UTIs. It is important

    when advising patients and their parents/carers (see below) to use

    the opportunity for recommendations on a healthy life style.

    Impairment of renal function in association with childhood

    UTI is very uncommon. In the rare occasion when this occurs it

    tends to be either a boy with congenital bilateral renal dysplasia

    or seen very rarely as acquired renal damage in girls from with

    recurrent febrile UTIs and very often associated bladder

    dysfunction. Studies show that there needs to be significant

    reduction in renal mass bilaterally.

    More long term studies such as the Swedish ones above are

    needed. In the meantime NICE recommends that once renal

    scarring is identified that the child has regular blood pressure

    readings as well as having the urine tested for proteinuria. It is

    important to add at least a yearly creatinine measurement to

    those children with bilateral scarring.

    Follow up

    Advice: following a UTI it is vital to give clear advice to parents/

    carers and young people about the symptoms of UTI and about

    the need for prompt recognition and treatment. They and their

    family doctors need to be made aware or reminded of the

    nonspecific nature of the symptoms of UTI and particularly that

    fevers should not be put down to a viral infection or teething

    unless a UTI has been ruled out. It is preferable to treat after a

    sample has been obtained and be prepared to stop after 48 hours

    if the cultures come back negative. Equally parents/carers need

    to know that if their baby fails to thrive, has a vomiting illness or

    persistent irritability that a UTI could be the reason and to seek

    medical advice promptly. Parents/carers and young children

    need to seek medical help again if symptoms do not settle within

    48 hours of starting treatment or if the child gets worse. In

    addition, advice needs to be given regarding prevention such as

    ensuring a good fluid intake, avoiding constipation andPAEDIATRICS AND CHILD HEALTH 24:7 291mass

    raised creatinine

    septicaemia

    failure to respond

    to treatment with

    suitable antibiotics

    within 48 hours

    infection with non

    E. coli organisms

    Children with an atypical UTI should have and ultrasound of

    their renal tract during the acute infection as they are more likely

    to have obstructive structural abnormalities. For further in-

    vestigations of children with atypical UTI please refer to the NICE

    Childhood UTI guidelines.

    Children with recurrent infections also need investiga-tion. NICE defined recurrent UTI as:

    two UTIs where at least one has been an AP/upper tract

    infection, or

    three or more episodes of cystitis/lower tract infection.

    A micturating cystourethrogram is no longer recommended

    for all infants with UTI. It should be considered in a young child

    with a febrile UTI and atypical features such as a history of

    antenatal hydronephrosis or ureteric or renal dilatation on ul-

    trasound, infection with non E. coli organisms, abnormal urine

    stream, or is found to have bright and small kidneys on ultra-

    sound (renal displasia) or has a degree of renal failure.abdominal or bladderp 2013enal tract imaging are

    clinical presentation

    as outlined above. A

    given below and this

    recommendations.

    al tract investigation

    seriously ill

    oor urine flowaddressing any issues around bladder function. It is helpful to

    give general advice regarding healthy life styles. If renal tract

    investigations are needed these need to be explained. It is helpful

    to have an advice leaflet to hand out.

    The investigation of the renal tract: historically a UTI was

    associated with concerns about vesicoureteric reflux which is

    diagnosed with a micturating cystourethrogram (MCUG). Over

    the last 5e7 years there has been a trend towards less imaging.

    Recent evidence suggests that VUR may be as common in children

    with UTI as those without. The NICE 2007 Childhood UTI

    guideline does not recommend looking for VUR after the first UTI

    and more recently the 2011 American Association of Paediatrics

    (AAP)s UTI guideline has also moved away from the routine use

    of the cystogram in infants with a first febrile UTI. A DMSA scan

    is no longer recommended in the AAP guidelines, which favour

    the use of the renal ultrasound instead. There is a different radi-

    ation load depending on the type of renal imaging algorithm used.

    Current recommendations fromNICEon rElsevier Ltd. All rights reserved.

  • There is a risk of introducing infection at the time of a MCUG

    and therefore it is recommended that prophylactic antibiotics

    should be given orally for 3 days with the MCUG taking place on

    the 2nd day. My personal practice is to use a full therapeutic dose

    ultimately to alternative ways of treating or preventing urine

    infections. A

    SYMPOSIUM: NEPHROLOGYduring these 3 days.

    Recurrent UTI: children with recurrent urine infections should be

    referred to a paediatric specialist. This has the purpose of identi-

    fying, investigating and managing potential reasons for re-

    currences and dealingwith any sequelae such as scarring. The first

    step is to identify the clinical features at the time of the infections

    and distinguish them from either vulvovaginitis or asymptomatic

    bacteriuria, classify the UTI recurrences into either cystitis or

    acute pyelonephritis episodes. It is also necessary through direct

    questioning to seek evidence for any continence abnormalities

    asking about micturition symptoms when well in between in-

    fections. This involves asking questions about the frequency of

    micturition, urgency, diurnal incontinence, hesitancy, staccato

    voiding and stress incontinence. Identification of constipation is

    important as it often is a risk factor for not only UTIs but it also

    aggravates continence problems. Close liaison with the paediatric

    continence service for their input is useful not only in managing

    constipation and continence problems and trying to achieve

    complete bladder emptying but also in performing uroflowmetry

    studieswhen the history suggests the possibility of a dysfunctional

    bladder. In such children, if the UTIs persist, consideration should

    be also given to performing an indirect cystogram to look for VUR.

    There will be the occasional child with recurrent, often febrile

    UTIs who fails to empty his/her bladder in the absence of outflow

    obstruction and in spite of a good fluid intake and absence of

    constipation, onwhom intermittent catheterizationwill need to be

    considered in order to prevent infections. In the child who con-

    tinues to have recurrent UTIs in spite of having addressed bladder

    or constipation problems it is worth considering a period of a few

    months on low dose antibiotic prophylaxis. Very rarely, in a child

    known to have VUR with abnormal bladder emptying, who con-

    tinues to have recurrent febrile UTIs an anti reflux procedure will

    need to be considered and discussed with a paediatric urologist.

    Clinic follow up: the three main groups of children requiring

    follow up are a) children with recurrent UTIs b) children who

    have a potentially clinically significant abnormal imaging

    needing paediatric urology referral c) children with renal scar-

    ring. In the light of the above studies on long term follow up it is

    very unlikely that the child with a single focal renal scar but

    normal individual kidney GFR on the DMSA scan will run into

    problems with hypertension unless he/she has further UTIs or

    has other risk factors for hypertension.

    Future research

    Further large scale studies are needed on the role of bladder

    dysfunction in recurrent UTI and renal damage. Antibacterial

    resistance is an increasing problem and ongoing research into the

    genetics of the host response to pathogens is likely to leadPAEDIATRICS AND CHILD HEALTH 24:7 292FURTHER READING

    Carpenter MA, Hoberman A, Mattoo TK, et al. for the RIVUR Trial In-

    vestigators. The RIVUR trial: profile and baseline clinical associations

    of children with vesicoureteral reflux. Pediatrics 2013; 132: e34e45.

    Downing H, Thomas-Jones E, Gal M, et al. The diagnosis of urinary tract

    infections in young children (DUTY): protocol for a diagnostic and

    prospective observational study to derive and validate a clinical al-

    gorithm for the diagnosis of UTI in children presenting to primary care

    with an acute illness. BMC Infect Dis 2012; 12: 158. http://www.

    biomedcentral.com/1471-2334/12/158.

    Finnell SM, Carroll AE, Downs SM. Technical report e diagnosis and

    management of an initial UTI in febrile infants and young children

    (American Association of Paediatrics). Pediatrics 2011; 128: e749e70.

    Godley ML, Desai D, Yeung CK, Dhillon HK, Duffy PG, Ransley PG. The

    relationship between early renal status, and the resolution of vesico-

    ureteric reflux and bladder function at 16 months. BJU Int 2001; 87:

    457e62.

    Hannula A, Perhomaa M, Venhola M, Pokka T, Renko M, Uhari M. Long-

    term follow-up of patients after childhood urinary tract infection. Arch

    Pediatr Adolesc Med 2012; 166: 1117e22.

    Hannula A, Venhola M, Renko M, Pokka T, Huttunen NP, Uhari M.

    Vesicoureteral reflux in children with suspected and proven urinary

    tract infection. Pediatr Nephrol 2010; 25: 1463e9.

    Health Survey for England 2008. Trend Tables. The NHS Information

    Centre for Health and Social Care.

    Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional

    elimination syndromes, primary vesicoureteral reflux and urinary tract

    infections in children. J Urol 1998; 160(3 Pt 2): 1019e22.

    La Scola C, De Mutiis C, Hewitt IK, et al. Different guidelines for imaging

    after first UTI in febrile infants: yield, cost, and radiation. Pediatrics

    2013; 131: e665e71.

    NICE guideline: urinary tract infections in children (diagnosis, treatment

    and long term management) August 2007.

    NICE. Urinary tract infection in children Evidence Update 48 October 2013.

    www.nice.org.uk.

    Sillen U, Brandstrom P, Jodal U, et al. The Swedish reflux trial in children:

    V. Bladder dysfunction. J Urol 2010; 184: 298e304.

    Svanborg C. Urinary tract infections in children: microbial virulence versus

    host susceptibility. Adv Exp Med Biol 2013; 764: 205e10.

    Toffolo A, Ammenti A, Montini G. Long-term clinical consequences of

    urinary tract infections during childhood: a review. Acta Paediatr 2012;

    101: 1018e31.

    Wennerstrom M, Hansson S, Hedner T, Himmelmann A, Jodal U. Ambu-

    latory blood pressure 16 to 26 years after the first urinary tract

    infection in childhood. J Hypertens 2000; 18: 485e91.

    Wennerstrom M, Hansson S, Jodal U, Sixt R, Stokland E. Renal function

    16 to 26 years after the first urinary tract infection. Arch Pediatr

    Adolesc Med 2000; 154: 339e45.

    Williams GJ, Craig JC, Carapetis JR. Preventing urinary tract infections in

    early childhood. Adv Exp Med Biol 2013; 764: 211e8. 2013 Elsevier Ltd. All rights reserved.

    Urinary tract infections in childrenDefinitionCausative organisms and host responseIncidence and epidemiologyClinical presentation and differential diagnosisUrine analysisManagement and treatment of UTIPrevention of UTILong term outcomeFollow upFuture researchFurther reading